Tinabinol

This classification denotes an antihypertensive agent with the molecular formula C23H34O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 455Y914AKK, chemically known as 1,2,3,5-tetrahydro-5,5-dimethyl-8-(1,2-dimethylheptyl)thiopyrano(2,3-c)(1)benzopyran-10-ol but generally known as tinabinol, which bears US NIH Compound Identifier 65443. European Medicines Agency schedules Tinabinol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11072MIG. The term TINABINOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). TINABINOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tinabinol under HS 29349990 and SITC 51579. As of Q4 2014, TINABINOL remains the US FDA Preferred Term for this commodity. Tinabinol bears US NLM identifiers UMLS ID C2699948 and NCI Concept Code C75242. SMILES: S1C2=C(c3c(OC2(C)C)cc(C(C(CCCCC)C)C)cc3O)CCC1.